Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 392

1.

A national study of adverse effects and global quality of life among candidates for curative treatment for prostate cancer.

Kyrdalen AE, Dahl AA, Hernes E, Småstuen MC, Fosså SD.

BJU Int. 2013 Feb;111(2):221-32. doi: 10.1111/j.1464-410X.2012.11198.x. Epub 2012 Jun 6.

2.

Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy.

Lilleby W, Fosså SD, Waehre HR, Olsen DR.

Int J Radiat Oncol Biol Phys. 1999 Mar 1;43(4):735-43.

PMID:
10098428
4.

Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.

Potosky AL, Davis WW, Hoffman RM, Stanford JL, Stephenson RA, Penson DF, Harlan LC.

J Natl Cancer Inst. 2004 Sep 15;96(18):1358-67.

PMID:
15367568
5.

Expanded Prostate Cancer Index Composite versus Incontinence Symptom Index and Sexual Health Inventory for Men to measure functional outcomes after prostatectomy.

Hedgepeth RC, Labo J, Zhang L, Wood DP Jr.

J Urol. 2009 Jul;182(1):221-7; discussion 227-8. doi: 10.1016/j.juro.2009.02.155. Epub 2009 May 17.

PMID:
19450842
6.

Sexual function with localized prostate cancer: active surveillance vs radical therapy.

van den Bergh RC, Korfage IJ, Roobol MJ, Bangma CH, de Koning HJ, Steyerberg EW, Essink-Bot ML.

BJU Int. 2012 Oct;110(7):1032-9. doi: 10.1111/j.1464-410X.2011.10846.x. Epub 2012 Jan 19.

7.

Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study.

Potosky AL, Legler J, Albertsen PC, Stanford JL, Gilliland FD, Hamilton AS, Eley JW, Stephenson RA, Harlan LC.

J Natl Cancer Inst. 2000 Oct 4;92(19):1582-92.

PMID:
11018094
8.

Quality of life impact of treatments for localized prostate cancer: cohort study with a 5 year follow-up.

Ferrer M, Guedea F, Suárez JF, de Paula B, Macías V, Mariño A, Hervás A, Herruzo I, Ortiz MJ, Ponce de León J, Sancho G, Boladeras A, Ayala A, Craven-Bratle J, Ávila M, Cunillera O, Pardo Y, Alonso J, Aguiló F; Clinically Localized Prostate Cancer.

Radiother Oncol. 2013 Aug;108(2):306-13. doi: 10.1016/j.radonc.2013.05.038. Epub 2013 Jul 9.

PMID:
23849168
10.

Defining sexual outcomes after treatment for localized prostate carcinoma.

Schover LR, Fouladi RT, Warneke CL, Neese L, Klein EA, Zippe C, Kupelian PA.

Cancer. 2002 Oct 15;95(8):1773-85.

11.

Quality of life and treatment outcomes: prostate carcinoma patients' perspectives after prostatectomy or radiation therapy.

Shrader-Bogen CL, Kjellberg JL, McPherson CP, Murray CL.

Cancer. 1997 May 15;79(10):1977-86.

PMID:
9149026
12.

Quality of life after radical prostatectomy or watchful waiting.

Steineck G, Helgesen F, Adolfsson J, Dickman PW, Johansson JE, Norlén BJ, Holmberg L; Scandinavian Prostatic Cancer Group Study Number 4.

N Engl J Med. 2002 Sep 12;347(11):790-6.

13.

Population-based study of long-term functional outcomes after prostate cancer treatment.

Carlsson S, Drevin L, Loeb S, Widmark A, Lissbrant IF, Robinson D, Johansson E, Stattin P, Fransson P.

BJU Int. 2016 Jun;117(6B):E36-45. doi: 10.1111/bju.13179. Epub 2015 Jun 23.

14.

Quality of life three years after diagnosis of localised prostate cancer: population based cohort study.

Smith DP, King MT, Egger S, Berry MP, Stricker PD, Cozzi P, Ward J, O'Connell DL, Armstrong BK.

BMJ. 2009 Nov 27;339:b4817. doi: 10.1136/bmj.b4817.

15.

Time course and predictors of symptoms after primary prostate cancer therapy.

Talcott JA, Manola J, Clark JA, Kaplan I, Beard CJ, Mitchell SP, Chen RC, O'Leary MP, Kantoff PW, D'Amico AV.

J Clin Oncol. 2003 Nov 1;21(21):3979-86.

PMID:
14581420
16.

[Epidemiology of urinary incontinence in prostate cancer. Incidence, quality of life and farmacoeconomic features].

Orsola A, Morote J.

Arch Esp Urol. 2009 Dec;62(10):786-92. Review. Spanish.

PMID:
20065528
17.

Health-related quality of life in early breast cancer.

Groenvold M.

Dan Med Bull. 2010 Sep;57(9):B4184.

PMID:
20816024
18.

Delayed rectal and urinary symptomatology in patients treated for prostate cancer by radiotherapy with or without short term neo-adjuvant androgen deprivation.

Christie D, Denham J, Steigler A, Lamb D, Turner S, Mameghan H, Joseph D, Matthews J, Franklin I, Atkinson C, North J, Poulsen M, Spry NA, Tai KH, Wynne C, Duchesne G, Kovacev O, Francis L, Kramar A, D'Este C, Bill D.

Radiother Oncol. 2005 Nov;77(2):117-25. Epub 2005 Nov 4.

PMID:
16271786
19.

Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 Years.

Barocas DA, Alvarez J, Resnick MJ, Koyama T, Hoffman KE, Tyson MD, Conwill R, McCollum D, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hashibe M, Kaplan SH, Paddock LE, Stroup AM, Wu XC, Penson DF.

JAMA. 2017 Mar 21;317(11):1126-1140. doi: 10.1001/jama.2017.1704. Erratum in: JAMA. 2017 May 23;317(20):2134.

20.

Supplemental Content

Support Center